Dengue Virus Human IgG Assay Control BC114G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Dengue Virus (DENV) Human IgG Assay Control, recombinant
Applications: ELISA
Suitable for IgG detection
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC114G Category: Virion/Serion kits Tags: Dengue Virus, ELISA control serum, IgG

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Dengue Virus reactive IgG
species reactivity	Dengue Virus
applications	ELISA
assay type	Indirect & quantitative
available size	1 mL

Dengue Virus Human IgG Assay Control BC114G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Form liquid
Associated products Dengue Virus superior Human IgM Assay Control (BC1141M) Dengue Virus Human IgM Assay Control (BC114M) Dengue Virus Human IgG Assay Control (BC114G) Dengue Virus superior IgM ELISA Kit (ESR1141M) Dengue Virus IgG ELISA Kit (ESR114G) Dengue Virus IgM ELISA Kit (ESR114M)

target relevance

human antibody anti-Dengue Virus

Dengue Virus

Description
Virus that causes dengue fever and severe dengue

Structure
Dengue virus (DENV) is an enveloped, positive-sense, single-stranded RNA virus belonging to the genus Flavivirus within the family Flaviviridae. Four antigenically distinct serotypes, designated DENV-1, DENV-2, DENV-3, and DENV-4, are capable of causing human disease. The virus is transmitted primarily through the bites of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus. Following transmission, dengue virus infects dendritic cells, monocytes, macrophages, and other susceptible cells before disseminating throughout the body. Infection with one serotype typically provides long-term immunity against that serotype but only partial and temporary protection against the others. Secondary infection with a different serotype may increase the risk of severe disease through antibody-dependent enhancement (ADE). Dengue virus is one of the most important mosquito-borne viral pathogens worldwide, particularly in tropical and subtropical regions.

Diagnosis
The diagnosis of dengue virus infection is performed through molecular, antigen detection, and serological methods. During the acute phase of illness, reverse transcription polymerase chain reaction (RT-PCR) and detection of the nonstructural protein 1 (NS1) antigen provide sensitive and specific identification of infection. Serological assays, including ELISA-based tests for dengue-specific IgM and IgG antibodies, are commonly used after the acute viremic phase. Interpretation of serological results may be complicated by cross-reactivity with other flaviviruses such as Zika virus, West Nile virus, and Yellow fever virus. Laboratory findings often include leukopenia, thrombocytopenia, elevated liver enzymes, and evidence of increased vascular permeability. Early laboratory confirmation is important for patient monitoring and management.

Symptoms
Dengue virus infection typically develops following an incubation period of approximately four to ten days after the bite of an infected mosquito. Classic dengue fever is characterized by sudden onset of high fever, severe headache, retro-orbital pain, muscle aches, joint pain, fatigue, nausea, vomiting, and a maculopapular rash. The intense muscle and joint pain has led to dengue being nicknamed 'breakbone fever.' Most infections are self-limiting and resolve within one to two weeks. However, a subset of patients develops severe dengue, formerly known as dengue hemorrhagic fever or dengue shock syndrome, characterized by plasma leakage, severe bleeding, thrombocytopenia, organ dysfunction, and circulatory shock. Severe dengue can be life-threatening and requires prompt medical management, particularly in children, elderly individuals, and patients experiencing secondary infection with a different dengue serotype.

Data

FAQ & Publications

Frequently Asked Questions

What is the recommended storage condition for the Dengue Virus Human IgG Assay Control BC114G?

The Dengue Virus Human IgG Assay Control BC114G should be stored at 2-8°C to maintain stability and performance.

Is the Dengue Virus Human IgG Assay Control BC114G suitable for ELISA applications targeting IgG detection?

Yes, this assay control is specifically designed for ELISA applications and is suitable for detecting Dengue Virus reactive IgG antibodies.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC114G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Dengue Virus Human IgG Assay Control BC114G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Cytomegalovirus IgG Control Serum BC109G

Borrelia burgdorferi IgG Control Serum BC121G

Echovirus IgG Control Serum BC135G

Bordetella pertussis IgG Control Serum BC120G

Echinococcus IgG Control Serum BC107G

Aspergillus fumigatus IgG Control Serum BC132G

Diphtheria IgG Control Serum BC130G

Adenovirus IgG Control Serum BC128G

Human Tropical Fever IgG Lateral flow dipstick kit 7872

Coxsackie IgG Virus Control Serum BC134G

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G

Brucella IgG Control Serum BC116G